SCHEMBL206174

SCHEMBL206174

COC(=O)c1cccc2oc(-c3ccc(C)cc3)nc12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 2/20 0.72
HSD17B10 Q99714 5/20 0.55
ALDH1A1 P00352 5/20 0.55
RAB9A P51151 5/20 0.55
SMN1; SMN2 Q16637 5/20 0.55
KDM4E B2RXH2 4/20 0.55
HPGD P15428 4/20 0.55
NPC1 O15118 4/20 0.55
MAPT P10636 3/20 0.55
NFKB1 P19838 1/20 0.55
NFKB2 Q00653 1/20 0.55
RELA Q04206 1/20 0.55
ATM Q13315 1/20 0.55
NPSR1 Q6W5P4 2/20 0.51
PKM P14618 1/20 0.51
HTR3A P46098 4/20 0.47
HTT P42858 1/20 0.47
CEPT1 Q9Y6K0 1/20 0.46
TP53 P04637 2/20 0.45
PTPN2 P17706 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17929361 0.94 TOP2A (0.83) TOP2AHSD17B10ALDH1A1RAB9ASMN1; SMN2
SCHEMBL7434524 0.89 TOP2A (0.88) TOP2AHSD17B10ALDH1A1RAB9ASMN1; SMN2
SCHEMBL2954779 0.88 TOP2A (0.70) TOP2AHSD17B10ALDH1A1RAB9ASMN1; SMN2
SCHEMBL143232 0.88 TOP2A (0.70) TOP2AHSD17B10ALDH1A1RAB9ASMN1; SMN2
SCHEMBL2964536 0.88 TOP2A (0.70) TOP2AHSD17B10ALDH1A1RAB9ASMN1; SMN2
SCHEMBL206232 0.86 TOP2A (0.56) TOP2AHSD17B10ALDH1A1RAB9ASMN1; SMN2
SCHEMBL28701666 0.85 TOP2A (0.66) TOP2AHSD17B10ALDH1A1RAB9ASMN1; SMN2
SCHEMBL205455 0.85 TOP2A (0.66) TOP2AHSD17B10ALDH1A1RAB9ASMN1; SMN2
SCHEMBL17929350 0.84 TOP2A (0.83) TOP2AHSD17B10ALDH1A1RAB9ASMN1; SMN2
SCHEMBL7022264 0.84 TOP2A (0.65) TOP2AHSD17B10ALDH1A1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088760-B2 Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP) BIOMARIN PHARMACEUTICAL INC. (US) 2012-01-03 US disclosed
US-20090197863-A1 BENZOXAZOLE CARBOXAMIDE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) LEAD THERAPEUTICS, INC. (US) 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090197863-A1 BENZOXAZOLE CARBOXAMIDE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) PARP1, PARP2, PARP11 TOP2A 70/4885HSD17B10 1316/4885ALDH1A1 398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.